Coordinating Clinical Trials in Psychopharmacology

Coordinating Clinical Trials in Psychopharmacology
Author :
Publisher :
Total Pages : 338
Release :
ISBN-10 : UCR:31210023565276
ISBN-13 :
Rating : 4/5 (76 Downloads)

Book Synopsis Coordinating Clinical Trials in Psychopharmacology by : Jerome Levine

Download or read book Coordinating Clinical Trials in Psychopharmacology written by Jerome Levine and published by . This book was released on 1979 with total page 338 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Coordinating Clinical Trials in Psychopharmacology Related Books

Coordinating Clinical Trials in Psychopharmacology
Language: en
Pages: 338
Authors: Jerome Levine
Categories: Drugs
Type: BOOK - Published: 1979 - Publisher:

DOWNLOAD EBOOK

Clinical Trials in Psychopharmacology
Language: en
Pages: 406
Authors: Marc Hertzman
Categories: Medical
Type: BOOK - Published: 2010-03-16 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

Although clinical trials were virtually unheard of in psychiatry for many years, they are now the gold standard for judging whether drugs are safe and useful. B
Clinical Psychopharmacology
Language: en
Pages: 601
Authors: S. Nassir Ghaemi
Categories: Medical
Type: BOOK - Published: 2018-12-05 - Publisher: Oxford University Press

DOWNLOAD EBOOK

Clinical Psychopharmacology offers a comprehensive guide to clinical practice that explores two major aspects of the field: the clinical research that exists to
Fundamentals of Clinical Psychopharmacology
Language: en
Pages: 172
Authors: Ian M. Anderson
Categories: Medical
Type: BOOK - Published: 2019-02-13 - Publisher: CRC Press

DOWNLOAD EBOOK

In the rapidly changing field of pharmacology, it is essential that all those involved in the prescribing or administering of medication to people with mental d
The Handbook of Psychopharmacology Trials
Language: en
Pages: 492
Authors: Marc Hertzman
Categories: Psychology
Type: BOOK - Published: 1997-06 - Publisher: NYU Press

DOWNLOAD EBOOK

Each year pharmaceutical companies invest billions of dollars in clinical trials of drugs used for the treatment of central nervous system diseases. Due to enor